KM
GILD icon

Kalos Management’s Gilead Sciences GILD Stock Holding History

Kalos Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,280
Closed -$203K – 68
2022
Q2 		$203K Sell
3,280
-200
-6% -$12.4K 0.27% 114
2022
Q1 		$206K Sell
3,480
-982
-22% -$62.8K 0.14% 145
2021
Q4 		$298K Buy
4,462
+212
+5% +$14.6K 0.08% 226
2021
Q3 		$284K Buy
4,250
+62
+1% +$4.36K 0.08% 225
2021
Q2 		$287K Sell
4,188
-369
-8% -$24.6K 0.12% 202
2021
Q1 		$303K Sell
4,557
-430
-9% -$27.7K 0.09% 221
2020
Q4 		$297K Sell
4,987
-498
-9% -$30.1K 0.13% 188
2020
Q3 		$343K Buy
5,485
+717
+15% +$49.7K 0.15% 160
2020
Q2 		$364K Sell
4,768
-100
-2% -$7.66K 0.15% 141
2020
Q1 		$366K Buy
4,868
+397
+9% +$27.4K 0.16% 137
2019
Q4 		$291K Hold
4,471
– – 0.11% 158
2019
Q3 		$277K Hold
4,471
– – 0.11% 150
2019
Q2 		$302K Buy
4,471
+351
+9% +$23.1K 0.14% 152
2019
Q1 		$267K Sell
4,120
-643
-13% -$42.7K 0.17% 122
2018
Q4 		$301K Sell
4,763
-720
-13% -$50.3K 0.15% 137
2018
Q3 		$404K Sell
5,483
-461
-8% -$34.8K 0.22% 107
2018
Q2 		$464K Buy
+5,944
New +$420K 0.21% 121
2018
Q1 		– Sell
-6,486
Closed -$494K – 154
2017
Q4 		$494K Buy
6,486
+3,054
+89% +$232K 0.23% 121
2017
Q3 		$278K Buy
+3,432
New +$262K 0.18% 125
2017
Q2 		– Sell
-3,820
Closed -$259K – 111
2017
Q1 		$259K Sell
3,820
-727
-16% -$51.1K 0.18% 119
2016
Q4 		$326K Sell
4,547
-189
-4% -$14K 0.26% 98
2016
Q3 		$375K Sell
4,736
-438
-8% -$35.6K 0.32% 90
2016
Q2 		$432K Sell
5,174
-86
-2% -$7.63K 0.33% 90
2016
Q1 		$488K Buy
+5,260
New +$474K 0.41% 78
2015
Q4 		– Hold
0
– – – 73

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kalos Management's GILD Position: Q3 2022 in Review

Kalos Management sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 3,280 shares — an estimated $203K sold.

Kalos Management first reported a position in GILD in Q1 2016 and held it in 24 quarters. The position peaked at $494K in Q4 2017. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • Kalos Management reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
  • Kalos Management sold 3,280 Gilead Sciences shares in Q3 2022, an estimated $203K.
  • Kalos Management first reported a position in Gilead Sciences in Q1 2016 and held it in 24 quarters.
  • Kalos Management's Gilead Sciences position peaked at $494K in Q4 2017.
  • 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Kalos Management's 13F filing for Q3 2022, filed 21 Nov 2022.